diarrhea while taking tirzepatide on (Mounjaro) affects approximately 23–31% of patients and is typically mild to moderate, transient, and most common during dose escalation. , It rarely requires discontinuation Tirzepatide and Diarrhea: Managing GLP-1

[1] [3] Rapid or excessive infusions can disturb electrolytes or cause fluid overload, though this is rare with proper dosing and monitoring

Lifestyle Modifications for Long-term Health While medications can be helpful, lifestyle changes are crucial for long-term weight management and improved health

SalB attenuated the activation and proliferation of retinal microglia and astrocytes induced by amyloid -protein deposition, along with the release of inflammatory factors through the -Secretase one pathway (Wang et al., 2023)

RESEARCH PURPOSES ONLY Type Single peptide Typical dose See product details for dosage information